» Articles » PMID: 29089064

Utilizing the Ultrasensitive Schistosoma Up-converting Phosphor Lateral Flow Circulating Anodic Antigen (UCP-LF CAA) Assay for Sample Pooling-strategies

Overview
Publisher Biomed Central
Date 2017 Nov 2
PMID 29089064
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Methodological applications of the high sensitivity genus-specific Schistosoma CAA strip test, allowing detection of single worm active infections (ultimate sensitivity), are discussed for efficient utilization in sample pooling strategies. Besides relevant cost reduction, pooling of samples rather than individual testing can provide valuable data for large scale mapping, surveillance, and monitoring.

Method: The laboratory-based CAA strip test utilizes luminescent quantitative up-converting phosphor (UCP) reporter particles and a rapid user-friendly lateral flow (LF) assay format. The test includes a sample preparation step that permits virtually unlimited sample concentration with urine, reaching ultimate sensitivity (single worm detection) at 100% specificity. This facilitates testing large urine pools from many individuals with minimal loss of sensitivity and specificity. The test determines the average CAA level of the individuals in the pool thus indicating overall worm burden and prevalence. When requiring test results at the individual level, smaller pools need to be analysed with the pool-size based on expected prevalence or when unknown, on the average CAA level of a larger group; CAA negative pools do not require individual test results and thus reduce the number of tests.

Results: Straightforward pooling strategies indicate that at sub-population level the CAA strip test is an efficient assay for general mapping, identification of hotspots, determination of stratified infection levels, and accurate monitoring of mass drug administrations (MDA). At the individual level, the number of tests can be reduced i.e. in low endemic settings as the pool size can be increased as opposed to prevalence decrease.

Conclusions: At the sub-population level, average CAA concentrations determined in urine pools can be an appropriate measure indicating worm burden. Pooling strategies allowing this type of large scale testing are feasible with the various CAA strip test formats and do not affect sensitivity and specificity. It allows cost efficient stratified testing and monitoring of worm burden at the sub-population level, ideally for large-scale surveillance generating hard data for performance of MDA programs and strategic planning when moving towards transmission-stop and elimination.

Citing Articles

Pre-vaccination and hookworm infections are associated with altered vaccine immune responses: a longitudinal analysis among adolescents living in helminth-endemic islands of Lake Victoria, Uganda.

Natukunda A, Zirimenya L, Nkurunungi G, Nassuuna J, Nkangi R, Mutebe A Front Immunol. 2024; 15:1460183.

PMID: 39267753 PMC: 11390495. DOI: 10.3389/fimmu.2024.1460183.


A comprehensive exploration of schistosomiasis: Global impact, molecular characterization, drug discovery, artificial intelligence and future prospects.

Ekloh W, Asafu-Adjaye A, Tawiah-Mensah C, Ayivi-Tosuh S, Quartey N, Aiduenu A Heliyon. 2024; 10(12):e33070.

PMID: 38988508 PMC: 11234110. DOI: 10.1016/j.heliyon.2024.e33070.


Flow-S: A Field-Deployable Device with Minimal Hands-On Effort to Concentrate and Quantify Circulating Anodic Antigen (CAA) from Large Urine Volumes.

de Jong D, Carrell C, Maganga J, Mhango L, Shigella P, Gill M Diagnostics (Basel). 2024; 14(8).

PMID: 38667466 PMC: 11048900. DOI: 10.3390/diagnostics14080820.


Schistosome infection among pregnant women in the rural highlands of Madagascar: A cross-sectional study calling for public health interventions in vulnerable populations.

Rakotozandrindrainy R, Rakotoarivelo R, Kislaya I, Marchese V, Rasamoelina T, Solonirina J PLoS Negl Trop Dis. 2024; 18(4):e0011766.

PMID: 38626192 PMC: 11051649. DOI: 10.1371/journal.pntd.0011766.


Insights into the epidemiology, pathogenesis, and differential diagnosis of schistosomiasis.

Ponzo E, Midiri A, Manno A, Pastorello M, Biondo C, Mancuso G Eur J Microbiol Immunol (Bp). 2024; 14(2):86-96.

PMID: 38498078 PMC: 11097794. DOI: 10.1556/1886.2024.00013.


References
1.
van Dam G, BOGITSH B, van Zeyl R, Rotmans J, Deelder A . Schistosoma mansoni: in vitro and in vivo excretion of CAA and CCA by developing schistosomula and adult worms. J Parasitol. 1996; 82(4):557-64. View

2.
Rollinson D, Knopp S, Levitz S, Stothard J, Tchuente L, Garba A . Time to set the agenda for schistosomiasis elimination. Acta Trop. 2012; 128(2):423-40. DOI: 10.1016/j.actatropica.2012.04.013. View

3.
Kremsner P, Enyong P, Krijger F, de Jonge N, Zotter G, Thalhammer F . Circulating anodic and cathodic antigen in serum and urine from Schistosoma haematobium-infected Cameroonian children receiving praziquantel: a longitudinal study. Clin Infect Dis. 1994; 18(3):408-13. DOI: 10.1093/clinids/18.3.408. View

4.
van Dam G, Bergwerff A, Thomas-Oates J, Rotmans J, Kamerling J, Vliegenthart J . The immunologically reactive O-linked polysaccharide chains derived from circulating cathodic antigen isolated from the human blood fluke Schistosoma mansoni have Lewis x as repeating unit. Eur J Biochem. 1994; 225(1):467-82. DOI: 10.1111/j.1432-1033.1994.00467.x. View

5.
Le L, Hsieh M . Diagnosing Urogenital Schistosomiasis: Dealing with Diminishing Returns. Trends Parasitol. 2017; 33(5):378-387. DOI: 10.1016/j.pt.2016.12.009. View